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At the end of 19th century a few fundamental discoveries
changed diagnostic and therapeutic possibilities in medicine
and, particularly, in oncology: in 1895 Wilhelm Roentgen
from Germany discovered X-rays, in 1886 Henry Becquerel
described the phenomenon of radioactivity of uranium, and
in 1898 Marie and Pierre Curie discovered radium and
polonium. In 1903 the Nobel Prize for Physics was
awarded jointly to Henry Becquerel, and Marie and Pierre
Curie for the discovery of radioactivity. Maria Skłodowska-
Curie received the 1911 Nobel Prize for Chemistry for her
discovery of radium and polonium (Fig. 1).
The discovery of X-rays by Roentgen was a turning
point in diagnostics. It enabled precise evaluation of
internal organs hitherto completely inaccessible for inves-
tigation. First, it became possible to visualize the bones
(one of the first X-rays in history was an X-ray of the hand
of Roentgen’s wife; Fig. 2); then, after introduction of
various contrast media (barium meal, iodine preparations)
other organs could also be visualized: the alimentary tract,
biliary routes, and blood vessels.
Even now radiology is an essential tool in modern
diagnosis and, sometimes, in the treatment of many
diseases. Modern techniques are, of course, more precise
and sophisticated. Computer analysis of X-ray images has
enabled the introduction of computer tomography (CT)
scans, which give a very precise view of the internal organs
inaccessible with classical methods. It is interesting to
know that to obtain a simple X-ray in the 1890s required
more than 30 minutes of exposure. Despite further
sophistication of the equipment, for example helix CT scan
and NMR (nuclear magnetic resonance), the discovery of
X-rays remains the basis of the technique.
Natural radioactivity, discovered by Becquerel and
Marie and Pierre Curie at the same time, led to new
therapeutic and diagnostic methods in medicine. First
clinical applications of radioactive substances were under-
taken very soon after. As early as 1899 Tage Sjoergren from
Sweden reported the first case of a malignant tumor of the
skin cured by use of radioactive source application.
Kassabian’s Medical Manual issued in 1907 in Phila-
delphia gives a list of tumors treated by radiotherapy. Many
of these are still treated with this method. Nowadays the
indications are more precise and the equipment is much
more sophisticated. One should also note that at that time
radiotherapy was also recommended in cases completely
unjustified according to our present knowledge, e.g.
varicose veins, epilepsy, acne, and others. However, even
at the time doctors observed harmful side effects of
radiotherapy, although first reports were rather anecdotal:
in July 1896 newspapers described the case of someone who
wanted to investigate, on himself, effect of radioactivity on
the skull and the brain—as result he lost all his hair.
Discovery of radium and polonium caused rapid and,
initially, completely uncontrolled use of radium in all fields of
life and medicine. The absence of proper dosimetric methods
and proper safety measures resulted in many complications
very often fatal—Marie Skłodowska-Curie experienced this
herself. Gaining experience in the side effects resulted in
elaboration of the modern principles of radiotherapy. Today’s
radiotherapy is an essential therapeutic method in oncology.
During the first 50 years external beam radiation was
based on the use of radium and X-rays. Now we use cobalt
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safeforthepatient andmedical staff.Introductionof computers
has enabled proper treatment planning, precise dosage, and
minimal impairment of surrounding normal tissues.
We can see also dynamic progress in another field of
radiotherapy i.e. brachytherapy. Greek term “brachy”
means “near”—in this case the radioactive source is in
direct contact with the tissue of the tumor. The first report
of effectively treatment with this method of basal cell
carcinoma of the skin was published in 1904 (Goldberg and
London). In 1904 a diagram showing the effect of a
magnetic field on the radium rays was published by
Cleaves. He gives the following commentary “The beta
rays are bent strongly to the right, the gamma rays as are
the x-rays are not bent at all, and the alpha rays are bent
very little to the left.” Earlier Pierre Curie demonstrated that
at least two different kinds of rays were emitted from
radioactive substances. Radium, discovered by Marie-
Skłodowska-Curie, was first used in brachytherapy. At the
very beginning it was placed directly on the surface of the
tumor or intracavitary (in cancer of the vagina or uterus).
Very soon, as early as the 1910s, doctors started to
introduce the radioactive source interstitially, i.e. deep into
the tumor. Cancers of the breast, prostate, esophagus, and
brain were among the first treated by this method. Because
of a lack of proper dosimetry and the inevitability of direct
contact with the radioactive material, the method was very
dangerous for the doctors who used it. The method was
substantially improved by use of radioactive isotopes with
the afterloading method. Cesium and iridium are new
isotopes in use. Modern computer software enables very
precise elaboration of effective and, simultaneously, safe
dosage; this is particularly important with increasing use of
high doses (HDR—high dose rate) in brachytherapy.
Brachytherapy is successfully used for treatment of cancer
of the genitourinary tract, head and neck cancers, and
carcinoma of the penis. In many cases its effectiveness is
similar to radical but sometimes mutilating surgery. In
advanced incurable cancer, brachytherapy can be used for
palliation, giving relief to the patient and offering some
comfort during the last months of his/her life. New
diagnostic and interventional methods in endoscopy and
radiology enable the use of various applicators without the
need for difficult and dangerous surgical intervention,
particularly for patients in poor condition. Brachytherapy
is very effective in palliative treatment of lung cancer,
esophageal cancer, and tumor of alimentary tract.
A relatively new technique based on the discoveries of
Marie Skłodowska-Curie is nuclear medicine which uses
substances labeled with radioisotopes introduced into the
organs of the patient for imaging of the tumors. Progress in
nuclear medicine was possible after the Second World War
when, after the discoveries of Frederic and Irene Joliot-
Curie from 1930s, it became possible to produce artificial
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(Fig. 3).
Radioactive isotopes of such elements as iodine, indium,
or technetium with relatively short half-lives can be used in
both diagnosis and therapy. They are being introduced into
organs in combination with other substances which selec-
tively bind to various tissues or tissue fluids. Reading of the
distribution of the radioactivity by use of gamma-cameras,
which substituted popular Geiger counters, enables location
of the cancer tissue or detection of the direction of
lymphatic flow. This is very often helpful to the oncologist
when choosing the proper tactics for treatment. Enormous
progress has been made during recent years in the
construction of devices giving a more precise view of the
organs investigated, for example SPECT (single photon
emission computed tomography) or, even better, PET
(positron emission tomography). A new device with
increasing possibilities for the surgeon is an intraoperative
detector of gamma radiation. The probe enables more
precise location of tumor tissue previously labeled with an
isotope and makes possible more radical procedures or, on
the other hand, enables evaluation of the inoperability of
the tumor. A new possibility for surgical removal of tumors
is RIGS—radioimmunoguided surgery.
The most urgent problem at the moment is elaboration of
substances which specifically bind to neoplasmatic tissue.
Progress here is significant, mostly because of the produc-
tion of better monoclonal antibodies. Nuclear medicine also
uses radioisotopes for treatment of cancer—by using
selective binding of iodine to thyroid tissue we can destroy
residual microscopic fragments of cancer tissue left after
surgery. At the moment this is only experimental, but
maybe other tumors will soon be treated by use of
monoclonal antibodies in clinical practice.
Cancer is still very often a mortal disease and if it is
cured patients suffer very much during the treatment and
sometimes become disabled at the cost of being alive.
However progress in oncology is visible, and with still
improving methods of early diagnosis and better therapeutic
methods the number of cured patients is still increasing.
Fig. 4 The Marie Skłodowska-Curie Memorial Cancer Center in
Warsaw Fig. 3 Frederic and Irene Joliot-Curie
Fig. 2 The first X-ray in history—the hand of Konrad Roentgen’s wife
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very important scientific investigations giving hope, and the
possibility of saving many people. Marie Skłodowska-
Curie was not a doctor but she recognized the value of her
discoveries for medicine. The Institute Curie in Paris and
the Radium Institute in Warsaw (now Marie Skłodowska-
Curie Memorial Cancer Center) were founded on the basis
of her inspiration (Fig. 4).
The activity of the Marie Skłodowska-Curie Memorial
Cancer Center includes not only the treatment of the
patients but, as Marie Curie wanted, research also. Every
clinical specialist should keep in mind that progress in
clinical medicine and every-day medical practice cannot
exist without progress in research. Marie Curie said:
“Therapeutic activity in such new field requires strong base
which is constituted by physical and chemistry studies of
new substances, if the base does not exist, theory becomes
just empiricism and routine use of indiscriminately popular
methods in which there are, sometimes fundamental,
mistakes” (Fig. 5).
“Therapy should be permanently backed up by scientific
research without which no progress is possible. Moreover,
the search for pure knowledge is one of the important needs
of mankind.” (From the welcoming speech of Marie
Skłodowska-Curie at the opening of Radium Institute in
Warsaw 29 May 1932.)
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